Each weekly injection maintains stable GLP-1 levels, directly activating the GLP-1 receptor in the brain's appetite centers and improving satiety signaling
In that case, you may wonder what sets it apart from other medical weight loss interventions
It is known that endogenous levels of GHK peptide naturally decline with age, from roughly 200 ng/ml at age 20 to 80 ng/ml at age 60 [3], and studies have shown that GHK-Cu can reset gene expression of human cells to a healthier state, which has led to breakthroughs in tissue regeneration and wound healing [4, 5, 6]
But it's fair to say that none of them creates a buzz quite like vitamin C
Neurotrophic small molecule analogs may be useful in configuring such strategies
Here are some of the most notable findings to date: The weight loss effectiveness of tirzepatide has been investigated in four phase 3 trials as part of the SURMOUNT program